MEDNAX Announces Pricing of $500 Million of 6.250% Senior Notes Due 2027

FORT LAUDERDALE, Fla.–(BUSINESS WIRE)–$MD #MEDNAX–MEDNAX, Inc. (NYSE: MD), announced today the pricing of $500 million
aggregate principal amount of its 6.250% senior notes due January 15,
2027 (the “Notes”). The Notes were offered to persons reasonably
believed to be qualified institutional buyers pursuant to Rule 144A
under the Securities Act of 1933, as amended (the “Securities Act”),
and outside the United States to persons other than U.S. persons in
reliance upon Regulation S under the Securities Act. The expected
closing date for the private placement of the Notes is November 13, 2018.

As previously announced, MEDNAX intends to use the net proceeds from the
offering to repay a portion of the indebtedness outstanding under its
senior unsecured revolving credit facility.

This announcement is neither an offer to sell nor a solicitation of an
offer to buy any of these securities and shall not constitute an offer,
solicitation, or sale in any jurisdiction in which such offer,
solicitation, or sale is unlawful. The securities will not be registered
under the Securities Act or any state securities laws, and unless so
registered, may not be offered or sold in the United States except
pursuant to an exemption from the registration requirements of the
Securities Act and applicable state laws.

ABOUT MEDNAX

MEDNAX, Inc. is a national health solutions partner comprised of the
nation’s leading providers of physician services. Physicians and
advanced practitioners practicing as part of MEDNAX are reshaping the
delivery of care within their specialties and subspecialties, using
evidence-based tools, continuous quality initiatives, clinical research
and telemedicine to enhance patient outcomes and provide high-quality,
cost-effective care. The Company was founded in 1979, and today, through
its affiliated professional corporations, MEDNAX provides services
through a network of more than 4,200 physicians in all 50 states and
Puerto Rico. In addition to its national physician network, MEDNAX
provides services to healthcare facilities and physicians in over 40
states through two complementary businesses, consisting of a management
services company and a consulting services company.

Forward-Looking Statements

Certain statements and information in this press release may be
deemed to contain forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995, Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934, as amended. Forward-looking statements may
include, but are not limited to, statements relating to our objectives,
plans and strategies, and all statements, other than statements of
historical facts, that address activities, events or developments that
we intend, expect, project, believe or anticipate will or may occur in
the future. These statements are often characterized by terminology such
as “believe”, “hope”, “may”, “anticipate”, “should”, “intend”, “plan”,
“will”, “expect”, “estimate”, “project”, “positioned”, “strategy” and
similar expressions, and are based on assumptions and assessments made
by MEDNAX’s management in light of their experience and their perception
of historical trends, current conditions, expected future developments
and other factors they believe to be appropriate. Any forward-looking
statements in this press release are made as of the date hereof, and
MEDNAX undertakes no duty to update or revise any such statements,
whether as a result of new information, future events or otherwise.
Forward-looking statements are not guarantees of future performance and
are subject to risks and uncertainties and include the risks and
uncertainties associated with market conditions and the satisfaction of
customary closing conditions related to the offering. Important factors
that could cause actual results, developments, and business decisions to
differ materially from forward-looking statements are described in
MEDNAX’s most recent Annual Report on Form 10-K and its Quarterly
Reports on Form 10-Q, including the sections entitled “Risk Factors”, as
well MEDNAX’s current reports on Form 8-K, filed with the Securities and
Exchange Commission.

Contacts

MEDNAX, Inc.
Charles Lynch, 954-384-0175, x-5692
Vice
President, Strategy and Investor Relations
charles_lynch@mednax.com

leverton

I have been involved with publishing and marketing for the past 32 years. My passion is helping people share their voice. I am able to do this through two important venues: One, with Area-Info.net where people can share everything from opinions to events to news. It is your choice! What do you want to share? Two, through a new program called America's Real Deal I am involved with to help business owners get their voice heard.I schedule speaking engagements with community groups and business groups to share my passion about the importance of "sharing your voice".Contact me directly at lee@leeeverton.coom for scheduling information.